Last updated 16 days ago

A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

442 patients around the world
Available in Argentina, Brazil, Spain
Hoffmann-La Roche
8Research sites
442Patients around the world
This study is for people with
Macular Degeneration
Age-related Macular Degeneration
Requirements for the patient
From 50 Years
All Gender
Medical requirements
Sites
Centro Oftalmológico Dr. Daniel Charles
Recruiting
Riobamba 841, CABA, Buenos Aires
Instituto Oftalmológico de Buenos Aires / Oftalmos
Recruiting
Av. Córdoba 1830, CABA, Buenos Aires
Grupo Laser Vision
Recruiting
DLA, Mariano Moreno 1397, S2000 Rosario, Santa Fe
Botelho Hospital da Visão
Recruiting
R. Dois de Setembro, 2958 - Itoupava Norte, Blumenau - SC, 89052-504
Vision Institute - IPEPO (IPEPO - Instituto da Visão - Vila Clementino)
Recruiting
R. Borges Lagoa, 1083 - 11º andar - Vila Clementino, São Paulo - SP, 04038-032
Retina Clinic
Recruiting
R. Estados Unidos, 1881 - Jardim America, São Paulo - SP, 01427-002
BOS - Banco de Olhos de Sorocaba | Hospital Oftalmológico de Sorocaba
Recruiting
R. Nabek Shiroma, 210 - Jardim Emilia, Sorocaba - SP, 18031-060
Universidad Federal de São Paulo - Unifesp
Recruiting
R. Sena Madureira, 1500 - Vila Clementino, São Paulo - SP, 04021-001
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy